Results 81 to 90 of about 24,629 (256)
Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes [PDF]
, 2017 Purpose: Tranexamic acid (TXA) is a widely used antifibrinolytic agent that can also cause a decrease in vascular permeability. We hypothesized that TXA could improve macular edema (ME) that is caused by an increase in retinal vascular permeability.
Gosho Masahiko +7 more
core +3 more sources
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Premature infants are at a heightened risk of intracerebral or intraventricular hemorrhages (IVH), which often lead to posthaemorrhagic hydrocephalus and necessitate the placement of a ventriculoperitoneal (VP) shunt. Here, we present a case involving suspected ICH, which led to multiloculated hydrocephalus, recurrent ventriculitis, and ...
Hannes Egermann +5 more
wiley +1 more source
Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation.
PLoS ONE, 2019 In the present study, we investigated the capabilities of a novel ultrasonic approach for real-time control of fibrinolysis under flow conditions. Ultrasonic monitoring was performed in a specially designed experimental in vitro system.
Dmitry A Ivlev +4 more
doaj +1 more source
Data in Brief, 2019 There is technology available for anti-thrombus with earthworms, but the procedure is complex and extracts protein with inferior purity. In order to develop a simplified process with a stronger purity of protease, we investigated the Lumbricus rubellus ...
Yuanyuan Dong +8 more
doaj +1 more source
Various aspects of thrombolysis and fibrinolysis [PDF]
, 1969 The author has described modern thrombolytic therapy of arterial and venous thrombosis and emboli by therapeutic fibrinolysis and other drugs also methods and effects of local and parenteral application of fibrinolysin preparations, dosage, control ...
Szirmai, E.
core +1 more source
Food Science &Nutrition, Volume 13, Issue 10, October 2025.Alkalihalobacillus wakoensis ATCC 21832 demonstrated excellent acid (95.6% survival at pH 2.5) and bile tolerance, produced catalase, protease, and nattokinase, and exhibited broad antimicrobial activity. The strain was sensitive to several antibiotics, formed moderate biofilm, showed high hydrophobicity, adhered to epithelial cells, and enhanced HepG ...
Ali Zarei +5 more
wiley +1 more source
BMC Biotechnology, 2012 Background Today, thrombosis is one of the most widely occurring diseases in modern life. Drugs with thrombolytic functions are the most effective methods in the treatment of thrombosis.
Yuan Jun +5 more
doaj +1 more source
The never ending success story of tranexamic acid in acquired bleeding
Haematologica, 2020 Tranexamic acid (TXA) is an anti-fibrinolytic agent that acts by inhibiting plasminogen activation and fibrinolysis. Although its first clinical use dates back more than 50 years, this hemostatic agent is still the object of intense clinical and ...
Massimo Franchini +1 more
doaj +1 more source
Diabetic Wound Repair: From Mechanism to Therapeutic Opportunities
MedComm, Volume 6, Issue 10, October 2025.Diabetic wound healing is compromised by chronic metabolic dysfunction that disrupts essential cellular processes. This review examines key predisposing factors, including neuropathy and vascular disease, characterizes dysfunction in critical cell types such as macrophages and fibroblasts, evaluates limitations of current models, compares established ...
Renyuan Wang +5 more
wiley +1 more source
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]
, 2010 <p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Awadh, M. +5 more
core +1 more source